Outcomes of definitive chemoradiation in patients with esophageal cancer

Sameh Mikhail, Lai Wei, Mohamed E. Salem, Tanios Bekaii-Saab

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

The incidence of esophageal cancer has risen dramatically in the Western world. Although surgical resection of esophageal tumors is considered the cornerstone of curative approaches in localized esophageal cancer, approximately 40% of patients who undergo chemoradiation followed by surgery will experience a recurrence. Additionally, surgical resection is not a viable option for many patients with locally advanced unresectable disease, poor general condition or whose condition deteriorated following chemoradiation. Several investigators have, therefore, attempted to evaluate the outcomes of definitive chemoradiation in patients with localized or locally advanced esophageal cancer. The outcomes of concurrent chemoradiation remain a matter of debate given the heterogenous study design and treatment regimens used in recent trials. Understanding the clinical benefit of chemoradiation is essential prior to recommending it as an alternative to surgery. In our review, we present the most recent studies evaluating the role of chemoradiation to better define the clinical outcomes of patients with special attention to overall survival.

Original languageEnglish (US)
Article number12506
JournalDiseases of the Esophagus
Volume30
Issue number2
DOIs
StatePublished - Feb 1 2017

Fingerprint

Esophageal Neoplasms
Western World
Research Personnel
Recurrence
Survival
Incidence
Neoplasms
Therapeutics

Keywords

  • Chemoradiation
  • Esophageal cancer
  • Esophagectomy
  • Outcomes
  • Survival

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Outcomes of definitive chemoradiation in patients with esophageal cancer. / Mikhail, Sameh; Wei, Lai; Salem, Mohamed E.; Bekaii-Saab, Tanios.

In: Diseases of the Esophagus, Vol. 30, No. 2, 12506, 01.02.2017.

Research output: Contribution to journalReview article

@article{7cc3f78bdaf14a669f6f7c8e0243947b,
title = "Outcomes of definitive chemoradiation in patients with esophageal cancer",
abstract = "The incidence of esophageal cancer has risen dramatically in the Western world. Although surgical resection of esophageal tumors is considered the cornerstone of curative approaches in localized esophageal cancer, approximately 40{\%} of patients who undergo chemoradiation followed by surgery will experience a recurrence. Additionally, surgical resection is not a viable option for many patients with locally advanced unresectable disease, poor general condition or whose condition deteriorated following chemoradiation. Several investigators have, therefore, attempted to evaluate the outcomes of definitive chemoradiation in patients with localized or locally advanced esophageal cancer. The outcomes of concurrent chemoradiation remain a matter of debate given the heterogenous study design and treatment regimens used in recent trials. Understanding the clinical benefit of chemoradiation is essential prior to recommending it as an alternative to surgery. In our review, we present the most recent studies evaluating the role of chemoradiation to better define the clinical outcomes of patients with special attention to overall survival.",
keywords = "Chemoradiation, Esophageal cancer, Esophagectomy, Outcomes, Survival",
author = "Sameh Mikhail and Lai Wei and Salem, {Mohamed E.} and Tanios Bekaii-Saab",
year = "2017",
month = "2",
day = "1",
doi = "10.1111/dote.12506",
language = "English (US)",
volume = "30",
journal = "Diseases of the Esophagus",
issn = "1120-8694",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Outcomes of definitive chemoradiation in patients with esophageal cancer

AU - Mikhail, Sameh

AU - Wei, Lai

AU - Salem, Mohamed E.

AU - Bekaii-Saab, Tanios

PY - 2017/2/1

Y1 - 2017/2/1

N2 - The incidence of esophageal cancer has risen dramatically in the Western world. Although surgical resection of esophageal tumors is considered the cornerstone of curative approaches in localized esophageal cancer, approximately 40% of patients who undergo chemoradiation followed by surgery will experience a recurrence. Additionally, surgical resection is not a viable option for many patients with locally advanced unresectable disease, poor general condition or whose condition deteriorated following chemoradiation. Several investigators have, therefore, attempted to evaluate the outcomes of definitive chemoradiation in patients with localized or locally advanced esophageal cancer. The outcomes of concurrent chemoradiation remain a matter of debate given the heterogenous study design and treatment regimens used in recent trials. Understanding the clinical benefit of chemoradiation is essential prior to recommending it as an alternative to surgery. In our review, we present the most recent studies evaluating the role of chemoradiation to better define the clinical outcomes of patients with special attention to overall survival.

AB - The incidence of esophageal cancer has risen dramatically in the Western world. Although surgical resection of esophageal tumors is considered the cornerstone of curative approaches in localized esophageal cancer, approximately 40% of patients who undergo chemoradiation followed by surgery will experience a recurrence. Additionally, surgical resection is not a viable option for many patients with locally advanced unresectable disease, poor general condition or whose condition deteriorated following chemoradiation. Several investigators have, therefore, attempted to evaluate the outcomes of definitive chemoradiation in patients with localized or locally advanced esophageal cancer. The outcomes of concurrent chemoradiation remain a matter of debate given the heterogenous study design and treatment regimens used in recent trials. Understanding the clinical benefit of chemoradiation is essential prior to recommending it as an alternative to surgery. In our review, we present the most recent studies evaluating the role of chemoradiation to better define the clinical outcomes of patients with special attention to overall survival.

KW - Chemoradiation

KW - Esophageal cancer

KW - Esophagectomy

KW - Outcomes

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=85005847971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85005847971&partnerID=8YFLogxK

U2 - 10.1111/dote.12506

DO - 10.1111/dote.12506

M3 - Review article

C2 - 27868290

AN - SCOPUS:85005847971

VL - 30

JO - Diseases of the Esophagus

JF - Diseases of the Esophagus

SN - 1120-8694

IS - 2

M1 - 12506

ER -